Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Merus N V | 3,874,182 | 4,472,840 | +598,658 | $162.91M | $188.26M | 13.87% | +$25.35M |
| Nuvalent Inc | 1,621,600 | 1,855,000 | +233,400 | $126.94M | $131.56M | 9.69% | +$4.62M |
| Enliven Therapeutics Inc | 4,205,000 | 4,675,000 | +470,000 | $94.61M | $92.00M | 6.78% | -$2.61M |
| Soleno Therapeutics Inc | 1,525,000 | 1,150,000 | -375,000 | $68.55M | $82.17M | 6.05% | +$13.62M |
| Xenon Pharmaceuticals Inc.(XENE) | 2,740,000 | 2,325,000 | -415,000 | $107.41M | $78.00M | 5.75% | -$29.40M |
| Alkermes plcSHS(ALKS) | 2,300,000 | 1,950,000 | -350,000 | $66.15M | $64.39M | 4.74% | -$1.76M |
| Agios Pharmaceuticals, Inc.(AGIO) | 0 | 2,185,000 | +2,185,000 | $0 | $64.02M | 4.72% | +$64.02M |
| Vaxcyte, Inc.(PCVX) | 1,625,000 | 1,650,000 | +25,000 | $133.02M | $62.30M | 4.59% | -$70.72M |
| Vera Therapeutics, Inc.CL A(VERA) | 1,958,600 | 2,561,782 | +603,182 | $82.83M | $61.53M | 4.53% | -$21.30M |
| Celldex Therapeutics, Inc.(CLDX) | 0 | 3,200,000 | +3,200,000 | $0 | $58.08M | 4.28% | +$58.08M |
| Scholar Rock Holding Corporation(SRRK) | 950,000 | 1,745,000 | +795,000 | $41.06M | $56.10M | 4.13% | +$15.04M |
| Cogent Biosciences, Inc.(COGT) | 6,881,629 | 8,892,816 | +2,011,187 | $53.68M | $53.27M | 3.93% | -$408.7K |
| Viridian Therapeutics, Inc.(VRDN) | 2,400,000 | 3,600,000 | +1,200,000 | $46.01M | $48.53M | 3.58% | +$2.52M |
| Nurix Therapeutics, Inc.(NRIX) | 3,000,000 | 3,978,907 | +978,907 | $56.52M | $47.27M | 3.48% | -$9.25M |
| Centessa Pharmaceuticals PlcADS | 2,218,425 | 2,367,578 | +149,153 | $37.16M | $34.05M | 2.51% | -$3.11M |
| Spyre Therapeutics, Inc.(SYRE) | 1,988,084 | 1,988,084 | 0 | $46.28M | $32.08M | 2.36% | -$14.20M |
| Pharvaris N V COM | 1,911,433 | 1,911,433 | 0 | $36.64M | $30.01M | 2.21% | -$6.63M |
| Mind Medicine Mindmed Inc | 4,308,425 | 4,525,000 | +216,575 | $29.99M | $26.47M | 1.95% | -$3.52M |
| Solid Biosciences Inc | 0 | 5,825,000 | +5,825,000 | $0 | $21.55M | 1.59% | +$21.55M |
| Bright Minds Biosciences Inc.(DRUG) | 500,000 | 500,000 | 0 | $18.01M | $18.04M | 1.33% | +$25.0K |
| Cardiff Oncology, Inc.(CRDF) | 5,384,616 | 5,384,616 | 0 | $23.37M | $16.91M | 1.25% | -$6.46M |
| Oruka Therapeutics, Inc.(ORKA) | 1,419,714 | 1,419,714 | 0 | $27.53M | $14.57M | 1.07% | -$12.96M |
| Inhibikase Therapeutics, Inc.(IKT) | 5,925,000 | 5,344,432 | -580,568 | $19.26M | $11.70M | 0.86% | -$7.55M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 2,000,000 | 2,000,000 | 0 | $16.14M | $11.16M | 0.82% | -$4.98M |
| Apogee Therapeutics Inc | 290,000 | 290,000 | 0 | $13.14M | $10.83M | 0.80% | -$2.30M |
| Neurogene Inc.(NGNE) | 800,000 | 925,000 | +125,000 | $18.29M | $10.83M | 0.80% | -$7.46M |
| Tyra Biosciences, Inc.(TYRA) | 0 | 950,000 | +950,000 | $0 | $8.84M | 0.65% | +$8.84M |
| Perceptive Cap Solutions CorCL A CL A ORD SHS | 750,000 | 750,000 | 0 | $7.63M | $7.72M | 0.57% | +$90.0K |
| Celcuity Inc.(CELC) | 400,000 | 695,650 | +295,650 | $5.24M | $7.03M | 0.52% | +$1.80M |
| Vistagen Therapeutics, Inc.(VTGN) | 1,575,000 | 1,575,000 | 0 | $4.65M | $3.94M | 0.29% | -$708.8K |
| Avalo Therapeutics, Inc.(AVTX) | 483,000 | 483,000 | 0 | $3.59M | $3.87M | 0.29% | +$280.1K |
| ABIVAX Société AnonymeADS(ABVX) | 1,284,110 | 0 | -1,284,110 | $9.40M | $0 | — | -$9.40M |
| Helix Acquisition Corp IiCL A | 500,000 | 0 | -500,000 | $5.25M | $0 | — | -$5.25M |
| Nkarta, Inc.(NKTX) | 351,848 | 0 | -351,848 | $876.1K | $0 | — | -$876.1K |
| Third Harmonic Bio Inc | 237,704 | 0 | -237,704 | $2.45M | $0 | — | -$2.45M |